Salem ML - Search Results

1

Anti-neoplastic and immunomodulatory potency of co-treatment based on bovine lactoferrin and/or muramyl dipeptide in tumor-bearing mice.

Ibrahim HM, Mohamed AH, Salem ML, Osman GY, Morsi DS. Ibrahim HM, et al. Among authors: salem ml. Toxicol Res (Camb). 2020 Apr 24;9(2):137-147. doi: 10.1093/toxres/tfaa012. eCollection 2020 Apr. Toxicol Res (Camb). 2020. PMID: 32440345 Free PMC article.

2

Acute inflammation induces immunomodulatory effects on myeloid cells associated with anti-tumor responses in a tumor mouse model.

Salem ML, Attia ZI, Galal SM. Salem ML, et al. J Adv Res. 2016 Mar;7(2):243-53. doi: 10.1016/j.jare.2015.06.001. Epub 2015 Jun 19. J Adv Res. 2016. PMID: 26966565 Free PMC article.

3

Beneficial Modulatory Effects of Treatment With Bone Marrow Lysate on Hematopoietic Stem Cells and Myeloid Cells in Tumor-Bearing Mice.

Salem ML, El-Bakry KA, Moubark EH, Sobh A, Khalil SM. Salem ML, et al. Br J Biomed Sci. 2022 Jun 29;79:10328. doi: 10.3389/bjbs.2022.10328. eCollection 2022. Br J Biomed Sci. 2022. PMID: 35996501 Free PMC article.

4

Comparative expression of caspases and annexin V in benign and malignant ovarian tumors.

Hassan HA, Salem ML, Gouida MS, El-Azab KM. Hassan HA, et al. Among authors: salem ml. J Cancer Res Ther. 2018 Jul-Sep;14(5):1042-1048. doi: 10.4103/0973-1482.187282. J Cancer Res Ther. 2018. PMID: 30197345 Free article.

5

Time-dependent changes in the glycolytic pathway in activated T cells are independent of tumor burden or anti-cancer chemotherapy.

Khalil SM, Eltaramsy A, Hegazi MM, Mohamed TM, Alwasel S, Salem ML. Khalil SM, et al. Among authors: salem ml. Int Immunopharmacol. 2023 Sep;122:110622. doi: 10.1016/j.intimp.2023.110622. Epub 2023 Jul 12. Int Immunopharmacol. 2023. PMID: 37451014

6

Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl₄- induced liver fibrosis in mice.

Elmahdy NA, Sokar SS, Salem ML, Sarhan NI, Abou-Elela SH. Elmahdy NA, et al. Among authors: salem ml. Biomed Pharmacother. 2017 May;89:1378-1386. doi: 10.1016/j.biopha.2017.03.007. Epub 2017 Mar 19. Biomed Pharmacother. 2017. PMID: 28320105

7

Correlations between MHLC scores and Indicators of Immune Response in Egyptian Women with Breast Cancer.

El-Baiomy EM, Salem ML, El-Amir A, Sabry NA, Wallston KA, El-Mashad N. El-Baiomy EM, et al. Among authors: salem ml. Gulf J Oncolog. 2020 Jan;1(32):7-11. Gulf J Oncolog. 2020. PMID: 32342912

8

A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine.

Abdellateif MS, Shaarawy SM, Kandeel EZ, El-Habashy AH, Salem ML, El-Houseini ME. Abdellateif MS, et al. Among authors: salem ml. Oncol Lett. 2018 Jul;16(1):529-535. doi: 10.3892/ol.2018.8631. Epub 2018 May 4. Oncol Lett. 2018. PMID: 29928442 Free PMC article.

9

Atorvastatin lowers breast cancer risk by reversing an early tumorigenic signature.

Foda MY, Salem ML, AlAkwaa FM, El-Khawaga OY. Foda MY, et al. Among authors: salem ml. Sci Rep. 2024 Aug 1;14(1):17803. doi: 10.1038/s41598-024-67706-2. Sci Rep. 2024. PMID: 39090164 Free PMC article.

10

Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.

Salem ML. Salem ML. Immunol Lett. 2011 Jun 30;137(1-2):9-14. doi: 10.1016/j.imlet.2011.02.019. Epub 2011 Feb 23. Immunol Lett. 2011. PMID: 21352854 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters